DR.SURBHI KANSAL; MAINSHA JAIN. IN VITRO SUSCEPTIBILITY PROFILES OF FTOLOZANE–TAZOBACTAM AND CEFTAZIDIME–AVIBACTAM AGAINST AMPC/ ESBL PRODUCING ENTEROBACTERIACEAE. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 33, n. 2, p. 841–852, 2026. DOI: 10.69980/1gsrfr34. Disponível em: https://jptcp.com/index.php/jptcp/article/view/13508. Acesso em: 2 oct. 2026.